A clinical study team is assessing the effect of a drug on memory, language, and learning for people with Down syndrome. This therapy is based on research from Stanford University.
They are conducting a clinical study to this effect in Australia. It has been approved by all the necessary local and national regulatory boards.
Currently, they want to inform interested individuals who might have/know someone who has Down syndrome in Tasmania